Taken together, these results suggest that association of TRAIL with co-targeting of MEK and PI3K/mTOR, or with MEK blockade only, promotes effective melanoma cell death by modulating key molecules involved in regulation of both the extrinsic and intrinsic apoptosis pathways. This evidence concerns the gene MAP2K7 and melanoma.